Olivier Costa

Twenty-Year Progression Rate to Clinical Onset According to Autoantibody Profile, Age, and <i>HLA-DQ</i> Genotype in a Registry-Based Group of Children and Adults With a First-Degree Relative With Type 1 Diabetes

Frans Gorus, Eric V. Balti, Anissa Messaaoui et al. · Diabetes Care · 2017 · 62 citations

Life Sciences, Endocrinology, Genetics +17

Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients

Frans Gorus, Eric V. Balti, Ilse Vermeulen et al. · Clinical & Experimental Immunology · 2012 · 48 citations · Full text

Life Sciences, Endocrinology, Immunology +16

An important minority of prediabetic first-degree relatives of type 1 diabetic patients derives from seroconversion to persistent autoantibody positivity after 10 years of age

Ilse Vermeulen, Ilse Weets, Olivier Costa et al. · Diabetologia · 2011 · 30 citations · Full text

Medicine, Endocrinology, Internal Medicine +8

Potential of UCHL1 as biomarker for destruction of pancreatic beta cells

Benedicte Brackeva, Veerle De Punt, Gertjan Kramer et al. · Journal of Proteomics · 2015 · 28 citations

Medicine, Molecular Biology, Pathology +11

Accelerated Progression to Type 1 Diabetes in the Presence of <i>HLA-A*24</i> and <i>-B*18</i> Is Restricted to Multiple Islet Autoantibody–Positive Individuals With Distinct <i>HLA-DQ</i> and Autoantibody Risk Profiles

Else M. Balke, Eric V. Balti, Bart Van Der Auwera et al. · Diabetes Care · 2018 · 24 citations

Life Sciences, Endocrinology, Genetics +17